Nutrisystem (NASDAQ:NTRI) was downgraded by analysts at Argus from a “buy” rating to a “hold” rating in a research note issued to investors on Tuesday, Marketbeat reports.
NTRI has been the topic of several other reports. Zacks Investment Research raised shares of Nutrisystem from a “hold” rating to a “buy” rating and set a $58.00 price target on the stock in a research report on Tuesday, December 19th. BidaskClub lowered shares of Nutrisystem from a “hold” rating to a “sell” rating in a research report on Tuesday, January 23rd. B. Riley set a $52.00 price target on shares of Nutrisystem and gave the stock a “buy” rating in a research report on Thursday, February 22nd. Citigroup dropped their price target on shares of Nutrisystem from $67.00 to $39.00 and set a “buy” rating on the stock in a research report on Monday, March 5th. Finally, Lake Street Capital reaffirmed a “buy” rating and set a $48.00 price target (down from $73.00) on shares of Nutrisystem in a research report on Tuesday, February 27th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and six have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $57.00.
Shares of Nutrisystem (NASDAQ NTRI) opened at $28.95 on Tuesday. Nutrisystem has a 1 year low of $28.50 and a 1 year high of $67.95. The stock has a market cap of $918.32, a price-to-earnings ratio of 15.24, a price-to-earnings-growth ratio of 0.89 and a beta of 1.03.
Nutrisystem (NASDAQ:NTRI) last posted its quarterly earnings results on Monday, February 26th. The company reported $0.42 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.40 by $0.02. Nutrisystem had a net margin of 8.30% and a return on equity of 48.69%. The firm had revenue of $131.20 million for the quarter, compared to analyst estimates of $128.75 million. During the same period in the prior year, the firm posted $0.29 earnings per share. The company’s quarterly revenue was up 20.5% compared to the same quarter last year. equities analysts predict that Nutrisystem will post 2.05 EPS for the current fiscal year.
In other news, insider Keira Krausz sold 5,000 shares of the stock in a transaction dated Thursday, January 11th. The shares were sold at an average price of $50.96, for a total value of $254,800.00. Following the transaction, the insider now directly owns 75,463 shares of the company’s stock, valued at $3,845,594.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Dawn M. Zier sold 30,006 shares of the stock in a transaction dated Friday, January 12th. The shares were sold at an average price of $52.36, for a total transaction of $1,571,114.16. Following the completion of the transaction, the chief executive officer now directly owns 224,659 shares in the company, valued at $11,763,145.24. The disclosure for this sale can be found here. Insiders sold 75,831 shares of company stock worth $3,566,319 over the last three months. Insiders own 2.40% of the company’s stock.
Several institutional investors and hedge funds have recently modified their holdings of NTRI. Polen Capital Management LLC bought a new position in shares of Nutrisystem in the fourth quarter valued at about $249,000. Ashford Capital Management Inc. bought a new position in shares of Nutrisystem in the third quarter valued at about $280,000. Los Angeles Capital Management & Equity Research Inc. bought a new position in shares of Nutrisystem in the third quarter valued at about $281,000. ClariVest Asset Management LLC raised its position in shares of Nutrisystem by 165.2% in the third quarter. ClariVest Asset Management LLC now owns 5,137 shares of the company’s stock valued at $287,000 after purchasing an additional 3,200 shares during the period. Finally, Nordea Investment Management AB raised its position in shares of Nutrisystem by 165.2% in the third quarter. Nordea Investment Management AB now owns 5,137 shares of the company’s stock valued at $287,000 after purchasing an additional 3,200 shares during the period.
WARNING: “Nutrisystem (NTRI) Stock Rating Lowered by Argus” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this report on another publication, it was copied illegally and republished in violation of United States and international trademark and copyright laws. The legal version of this report can be viewed at https://www.dispatchtribunal.com/2018/03/22/nutrisystem-ntri-stock-rating-lowered-by-argus.html.
Nutrisystem Company Profile
Nutrisystem, Inc, together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers weight loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. It also provides Nutrisystem Lean13 program, which provides weight loss, and support and counseling services; the South Beach Diet, a weight-loss program; and Nutrisystem 5-day kit, a ?D' kit that offers individuals with or at risk of type 2 diabetes.
Receive News & Ratings for Nutrisystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrisystem and related companies with MarketBeat.com's FREE daily email newsletter.